ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer

Chen, Dexin; Chen, Hao; Chi, Liangjie; Fu, Meiting; Wang, Guangxing; Wu, Zhida; Xu, Shuoyu; Sun, Caihong; Xu, Xueqin; Lin, Liyan; Cheng, Jiaxin; Jiang, Wei; Dong, Xiaoyu; Lu, Jianping; Zheng, Jixiang; Chen, Gang; Li, Guoxin; Zhuo, Shuangmu*; Yan, Jun*南方医科大学; 1
JAMA Network Open2021-11-30DOI: 10.1001/jamanetworkopen.2021.36388
10被引17阅读
引用收藏
分享

摘要

IMPORTANCE The current TNM staging system provides limited information for prognosis prediction and adjuvant chemotherapy benefits for patients with gastric cancer (GC). @@@ OBJECTIVE To develop a tumor-associated collagen signature of GC (TACS(GC)) in the tumor microenvironment to predict prognosis and adjuvant chemotherapy benefits in patients with GC. @@@ DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study included a training cohort of 294 consecutive patients treated between January 1, 2012, and December 31, 2013, from Nanfang Hospital, Southern Medical University, People's Republic of China, and a validation cohort of 225 consecutive patients treated between October 1, 2010, and December 31, 2012, from Fujian Provincial Cancer Hospital, Fujian Medical University, People's Republic of China. In total, 146 collagen features in the tumor microenvironment were extracted with multiphoton imaging. A TACS(GC) was then constructed using the least absolute shrinkage and selection operator Cox proportional hazards regression model in the training cohort. Data analysis was conducted from October 1, 2020, to April 30, 2021. @@@ MAIN OUTCOMES AND MEASURES The association of TACS(GC) with disease-free survival (DFS) and overall survival (OS) was assessed. An independent external cohort was included to validate the results. Interactions between TACS(GC) and adjuvant chemotherapy were calculated. @@@ RESULTS This study included 519 patients (median age, 57 years [IQR, 49-65 years]; 360 [69.4%] male). A 9 feature-based TACS(GC) was built. A higher TACS(GC) level was significantly associated with worse DFS and OS in both the training (DFS: hazard ratio [HR], 3.57 [95% CI, 2.45-5.20]; OS: HR, 3.54 [95% CI, 2.41-5.20]) and validation (DFS: HR, 3.10 [95% CI, 2.26-4.27]; OS: HR, 3.24 [95% CI, 2.33-4.50]) cohorts (continuous variable, P < .001 for all comparisons). Multivariable analyses found that carbohydrate antigen 19-9, depth of invasion, lymph node metastasis, distant metastasis, and TACS(GC) were independent prognostic predictors of GC, and 2 integrated nomograms that included the 5 predictors were established for predicting DFS and OS. Compared with clinicopathological models that included only the 4 clinicopathological predictors, the integrated nomograms yielded an improved discrimination for prognosis prediction in a C index comparison (training cohort: DFS, 0.80 [95% CI, 0.73-0.88] vs 0.78 [95% CI, 0.71-0.85], P = .03; OS, 0.81 [95% CI, 0.75-0.88] vs 0.80 [95% CI, 0.73-0.86], P = .03; validation cohort: DFS, 0.78 [95% CI, 0.70-0.87] vs 0.76 [95% CI, 0.67-0.84], P = .006; OS, 0.78 [95% CI, 0.69-0.86] vs 0.75 [95% CI, 0.67-0.84], P = .002). Patients with stage II and III GC and low TACS(GC) levels rather than high TACS(GC) levels had a favorable response to adjuvant chemotherapy (DFS: HR, 0.65 [95% CI, 0.43-0.96]; P = .03; OS: HR, 0.55 [95% CI, 0.36-0.82]; P = .004; dichotomized variable, P < .001 for interaction for both comparisons). @@@ CONCLUSIONS AND RELEVANCE The findings suggest that TACS(GC) provides additional prognostic information for patients with GC and may distinguish patients with stage II and III disease who are more likely to derive benefits from adjuvant chemotherapy.

学科与关键词

关键词
OPEN-LABELSTAGE-IIPREDICTIONMICROSCOPYLASSOCAPECITABINEOXALIPLATINSELECTIONSURVIVALFEATURES
相关
加载中…
  • Prognostic and predictive value of a pathomics signature in gastric cancer
    Chen, Dexin; Fu, Meiting; Chi, Liangjie; Lin, Liyan; Cheng, Jiaxin; Xue, Weisong; Long, Chenyan; Jiang, Wei; Dong, Xiaoyu; Sui, Jian; Lin, Dajia; Lu, Jianping; Zhuo, Shuangmu*; Liu, Side*; Li, Guoxin*; Chen, Gang*; Yan, Jun*Nature Communications, 2022, 13(1): 6903.被引 23
  • Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer
    Jiang, Yuming*; Xie, Jingjing; Huang, Weicai; Chen, Hao; Xi, Sujuan; Han, Zhen; Huang, Lei; Lin, Tian; Zhao, Li-Ying; Hu, Yan-Feng; Yu, Jiang; Cai, Shi-Rong*; Li, Tuanjie*; Li, Guoxin*Cancer Immunology Research, 2019, 7(12): 2065-2073.被引 81
  • An artificial intelligence method to assess the tumor microenvironment with treatment outcomes for gastric cancer patients after gastrectomy
    Chen, Tao*; Li, Xunjun; Mao, Qingyi; Wang, Yiyun; Li, Hanyi; Wang, Chen; Shen, Yuyang; Guo, Erjia; He, Qinglie; Tian, Jie; Zhu, Mansheng; Wu, Jing; Liang, Weiqi; Liu, Hao; Yu, Jiang; Li, Guoxin*Journal of Translational Medicine, 2022, 20(1): 100.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
JAMA Network Open
发表日期
2021-11-30
卷期
第 4 卷, 第 11 期
页码
e2136388
DOI
10.1001/jamanetworkopen.2021.36388
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82103041, 82102693, 81773117, 81771881]; Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Cancer [2020B121201004]; Guangdong Provincial Major Talents Project [2019JC05Y361]; Natural Science Foundation of Fujian Province [2018J07004]; Joint Funds of Fujian Provincial Health and Education Research [2019-WJ-21]; Science and Technology Program of Fujian Province [2018Y2003, 2019L3018, 2019YZ016006]; Clinical Research Project of Nanfang Hospital [2018CR034, 2020CR001]

作者

  • C

    Chen, Dexin (第一作者)

    jimei univ · 1 · southern med univ

  • C

    Chen, Hao

    1 · southern med univ

查看全部 19 位作者收起作者
  • C

    Chi, Liangjie

    1 · southern med univ · fujian med univ · fujian prov hosp

  • F

    Fu, Meiting

    1 · southern med univ

  • W

    Wang, Guangxing

    fujian normal univ

  • W

    Wu, Zhida

    fujian canc hosp · fujian med univ

  • X

    Xu, Shuoyu

    1 · southern med univ

  • S

    Sun, Caihong

    fujian normal univ

  • X

    Xu, Xueqin

    fujian normal univ

  • L

    Lin, Liyan

    fujian canc hosp · fujian med univ

  • C

    Cheng, Jiaxin

    1 · southern med univ

  • J

    Jiang, Wei

    1 · southern med univ

  • D

    Dong, Xiaoyu

    1 · southern med univ

  • L

    Lu, Jianping

    fujian canc hosp · fujian med univ

  • Z

    Zheng, Jixiang

    1 · southern med univ

  • C

    Chen, Gang

    fujian canc hosp · fujian med univ

  • L

    Li, Guoxin

    1 · southern med univ

  • Z

    Zhuo, Shuangmu (通讯)

    jimei univ

  • Y

    Yan, Jun (通讯)

    1 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417